Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Deoxypodophyllotoxin

SKU: orb1220013

Description

Deoxypodophyllotoxin shows cytotoxic , antineoplastic, antitumor, insecticidal, anti-angiogenic, vascular disrupting, insecticidal, antiviral, and anti-inflammatory activities.Deoxypodophyllotoxin (DPT) induced both apoptosis and autophagy via production of mitochondrial reactive oxygen species (ROS). DPT suppressed the PI3K/AKT/mTOR signaling cascades to lead autophagy process, resulting from conversion of light chain 3-I (LC3-I) into LC3-II and acidic vesicular organelles (AVOs) formation. Even if DPT-induced ROS were occurred in both apoptosis and autophagy, inhibition of ROS generation enhanced cell viability. Otherwise, 3-methyladeine (3-MA) impeding on autophagy accelerated an apoptotic response caused by DPT. Therefore, these findings suggest that DPT triggers cytoprotective autophagy against cytotoxic apoptosis.

Images & Validation

Key Properties

CAS Number19186-35-7
MW398.41
Purity>98% (HPLC)
FormulaC22H22O7
SMILES[H][C@]12COC(=O)[C@]1([H])[C@H](c1cc(OC)c(OC)c(OC)c1)c1cc3OCOc3cc1C2
TargetMicrotubule/Tubulin
SolubilityIn Vitro: DMSO : 100 mg/mL (251.00 mM)

Bioactivity

In Vivo
Deoxypodophyllotoxin (intravenously injected; 5, 10, and 20 mg/kg; 3 times a week; 28 days) suppresses the tumors in a dose-dependent manner, the growth of tumors is inhibited by 22.19%, 47.91% and 50.93% with DPT at 5, 10 and 20 mg/kg, respectively. Animal model: Xenograft model of gastric cancer in nude mice with SGC-7901 cells. Dosage: 5, 10, and 20 mg/kg. Administration: Intravenously injected; 5, 10, and 20 mg/kg; 3 times a week; 28 days. Result: Inhibited the growth of gastric cancer tumors.
In Vitro
Deoxypodophyllotoxin (25-75 nM; 6-48 hours) increases the percentage of early apoptotic cell populationfrom 2.05 to 5.62 and 18.49% for 24 h and 48 h, respectively. Deoxypodophyllotoxin (25-75 nM; 6-48 hours) treats SGC-7901 cells arrested in G2/M phase in time- and dose- dependent manners. Deoxypodophyllotoxin (25-75 nM; 6-48 hours) results in a remarkably time- and dose-dependent decrease in Cdc2 and Cdc25C expression levels and increases cyclin B1 within 6h, decreases PARP, Bcl-2 and caspase-3 activity. Apoptosis Analysis Cell line: SGC-7901 cells. Concentration: 25, 50, 75 nM. Incubation time: 6, 12, 24, 48 hours. Result: Induced apoptosis in SGC-7901 Cells. Cell Cycle Analysis Cell line: SGC-7901 cells. Concentration: 25, 50, 75 nM. Incubation time: 6, 12, 24, 48 hours. Result: Induced G2/M cell cycle arrest in SGC-7901 Cells Western blot analysis. Cell line: SGC-7901 cells. Concentration: 25, 50, 75 nM. Incubation time: 6, 12, 24, 48 hours. Result: Altered the expression of cyclin B1, Cdc2, Cdc25C, p-PARP, Bcl-2 and p-caspase-3 proteins.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Deoxypodophyllotoxin [orb1297562]

    99.21% (May vary between batches)

    19186-35-7

    398.41

    C22H22O7

    5 mg, 10 mg, 1 ml x 10 mM (in DMSO), 2 mg
  • Isoanthricin [orb1690336]

    69222-20-4

    398.41

    C22H22O7

    25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 460.00
10 mg
$ 780.00
25 mg
$ 1,230.00
50 mg
$ 1,670.00
100 mg
$ 2,230.00